Valneva’s growth potential lies in Ixchiq, but risks remain. Find out why VALN stock is still a Buy with a good long-term ...
Zika transmission has been reported in more than 90 countries as the spread of the Aedes aegypti mosquito that carries the ...
India experiences the world’s absolute burden of at least 11 NTDs, including hookworm, dengue, lymphatic filariasis, leprosy, ...
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today reported further positive Phase 3 data in adolescents for its single-shot chikungunya virus (CHIKV) vaccine, IXCHIQ ® ...
Valneva’s vaccine was highly immunogenic in both dose groups. A full dose of the vaccine exhibited a more robust immune response compared to a half dose by providing protective antibody titers already ...
Pune is battling a growing health crisis as Guillain-Barre Syndrome (GBS), a rare immunological nerve disorder, has gripped ...
Valneva has shared positive results from a late-stage study of its single-dose chikungunya vaccine in adolescents aged 12 to ...
Valneva chikungunya vaccine shows strong, sustained immune response in adolescents, supporting potential approvals in Brazil and other regions.
Zika transmission has been reported more than 90 countries as the spread of the Aedes aegypti mosquito that carries the virus, as well as dengue and ...
The FDA is reviewing new vaccines for meningitis and chikungunya and therapies for Parkinson disease and PTSD.
India has reported a total of 151 Zika virus disease (ZVD) between January 1 and December 31, 2024, according to the latest update by the World Health Organization (WHO). The cases were reported from ...